HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 233/11/1469    most recent 0803-RM-97v1 Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Knipping, K. Articles by Garssen, J. Search for Related Content PubMed PubMed Citation Articles by Knipping, K. Articles by Garssen, J.

---

ORIGINAL RESEARCH ARTICLE

In Vitro and In Vivo Anti-Allergic Effects of Arctium lappa L.

Karen Knipping^*,1, Elisabeth C. A. M. van Esch^*, Selva C. Wijering^*, Sicco van der Heide, Anthony E. Dubois and Johan Garssen^*

^* Department of Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands; and Department of Allergology, University Medical Centre Groningen, Groningen, The Netherlands

To whom requests for reprints should be addressed at ¹ University of Utrecht, Department of Pharmaceutical Sciences, Sorbonnelaan 16, 3508 TC Utrecht, The Netherlands. E-mail: c.t.knipping{at}uu.nl

The discovery of drugs that can be used for the treatment of allergic disease is important in human health. Arctium lappa Linne (Compositae) (AL) has been used as a traditional medicine in Brazil and throughout Asia and is known to have an anti-inflammatory effect. In this study, the inhibitory effects of AL on degranulation and the release of mediators as well as on inhibition of cys-leukotriene biosynthesis by basophils were investigated. AL was selected out of 10,000 herbal extracts in a set-up for high throughput screening in which the degree of degranulation was monitored by the release of β-hexosaminidase from rat basophil leukemia (RBL-2H3) cells. The AL extract significantly reduced degranulation and biosynthesis of cys-leukotrienes of human basophils in peripheral blood mono-nuclear cells (PBMCs) (50% inhibitory concentration [IC₅₀] = 8.3 and 11.4 µg/ml, respectively). Viability and metabolic activity of the PBMCs were not affected. Although arctiin, the active component of AL that has been described in the literature, was not able to reduce degranulation in RBL-2H3 cells, a single high-performance liquid chromatography (HPLC) fraction from the AL extract inhibited β-hexosaminidase release (IC₅₀ = 22.2 µg/ml). Topical administration of an aqueous extract of AL (5 mg/ear) on the ear of whey-sensitized mice 4 hrs before challenge with whey in the ear inhibited acute ear swelling by 50% in an in vivo cow’s milk allergic model. The extract had no effect in this model when administered orally. In conclusion, the active component present in the active HPLC fraction of the AL extract was able to significantly reduce the release of inflammatory mediators through inhibition of degranulation and cys-leukotriene release in vitro. In addition, this active component was able to inhibit acute skin response in mice in vivo, indicating that AL is a very promising natural component for use in anti-allergic treatment.

Key Words: Arctium lappa • anti-allergic • degranulation • leukotriene